Pharma M&A versus alliances and its underlying value drivers

Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective

AvHeiko Schön

Inbunden, Engelska, 2015

Del 15 i serien Corporate Finance and Governance

719 kr

Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.

Beskrivning

From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.

Produktinformation

Utgivningsdatum:2015-09-28
Mått:148 x 210 x 17 mm
Vikt:360 g
Format:Inbunden
Språk:Engelska
Serie:Corporate Finance and Governance
Antal sidor:201
Upplaga:15001
Förlag:Peter Lang AG
ISBN:9783631663813

Utforska kategorier

Nationalekonomi inom Ekonomi och Ledarskap
Ledarskapsböcker inom Ekonomi och Ledarskap
Organisationsteori inom Ekonomi och Ledarskap

Mer om författaren

Heiko Schön studied international business administration at Wiesbaden Business School. He was scholar of the German National Merit Foundation (sdw), he owns an Executive MBA from the University of Münster and earned his PhD at the University of Darmstadt. He brings in 10 years of experience in the pharmaceutical and chemical industry.

Innehållsförteckning

Contents: The Pharmaceutical Industry and its Paradigm Shift – The Pharmaceutical Industry and Mergers & Acquisitions – Value Creation in Pharmaceutical M&A and its underlying Value Drivers – The Pharmaceutical Industry and Alliances – Value Creation in Pharmaceutical In-licensings and its underlying Value Drivers – M&A versus In-licensing.